
Sign up to save your podcasts
Or


Send us a text
Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
By Dr. John Fralick and Dr. Michael Fralick5
1212 ratings
Send us a text
Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

43,710 Listeners

318 Listeners

539 Listeners

499 Listeners

887 Listeners

792 Listeners

3,357 Listeners

112,586 Listeners

56,830 Listeners

1,146 Listeners

65 Listeners

8,624 Listeners

515 Listeners

368 Listeners

425 Listeners